Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Lipella Pharmaceuticals Inc. (LIPO) had Earnings per Share (EPS) (Basic) of $-0.31 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.09M |
|
$-1.33M |
|
-- |
|
$0.09M |
|
$1.44M |
|
$-1.36M |
|
$0.03M |
|
$-1.33M |
|
$-1.33M |
|
$-1.33M |
|
$-1.33M |
|
$-1.33M |
|
$-1.33M |
|
$-1.36M |
|
$-1.36M |
|
4.30M |
|
4.30M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.31 |
$-0.31 |
|
| Balance Sheet Financials | |
$3.44M |
|
$0.01M |
|
$0.28M |
|
$3.72M |
|
$0.75M |
|
-- |
|
$0.23M |
|
$0.98M |
|
$2.74M |
|
$2.74M |
|
$2.74M |
|
4.47M |
|
| Cash Flow Statement Financials | |
$-2.86M |
|
-- |
|
$3.46M |
|
$2.18M |
|
$2.78M |
|
$0.60M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1564.19% |
|
-1564.19% |
|
-- |
|
-1530.65% |
|
-1530.65% |
|
$-2.86M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
2.07 |
|
43.57 |
|
-48.42% |
|
-48.42% |
|
-35.68% |
|
-48.42% |
|
$0.61 |
|
$-0.66 |
|
$-0.66 |
|